Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation

Journal of Proteome Research

Volumn 8, Issue 8, 2009, Pages 3791-3796

  Garcia, Jacob ^a   Faca, Vitor ^b   Jarzembowski, Jason ^c   Zhang, Qing ^b   Park, Julie ^d   Hanash, Samir ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Cell surface; LC MS MS; Neuroblastoma; Protein fractionation; Sy5Y

Indexed keywords

BETA1 INTEGRIN; CD147 ANTIGEN; CD51 ANTIGEN; CELL MEMBRANE PROTEIN; CELL SURFACE PROTEIN; CILIARY NEUROTROPHIC FACTOR RECEPTOR; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE L1; PROTEOME;

ARTICLE; CANCER CLASSIFICATION; CELL SURFACE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ANTIGENS, CD147; CELL LINE, TUMOR; CILIARY NEUROTROPHIC FACTOR; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEURAL CELL ADHESION MOLECULES; NEUROBLASTOMA; PROTEOME; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 68549122966     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800964v     Document Type: Article

References (36)

1. Perez, C. A.; Matthay, K. K.; Atkinson, J. B.; Seeger, R. C.; Shimada, H.; Haase, G. M.; Stram, D. O.; Gerbing, R. B.; Lukens, J. N. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J. Clin. Oncol. 2000, 18 (1), 18-26.
2. Yanik, G. A.; Levine, J. E.; Matthay, K. K.; Sisson, J. C.; Shulkin, B. L.; Shapiro, B.; Hubers, D.; Spalding, S.; Braun, T.; Ferrara, J. L.; Hutchinson, R. J. Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. J. Clin. Oncol. 2002, 20 (8), 2142-9.
3. Shimada, K.; Sano, T.; Sakamoto, Y.; Kosuge, T. A long-term followup and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005, 104 (9), 1939-47.
4. Jang, J. H.; Hanash, S. Profiling of the cell surface proteome. Proteomics 2003, 3 (10), 1947-54.
5. Faca, V. M.; Ventura, A. P.; Fitzgibbon, M. P.; Pereira-Faca, S. R.; Pitteri, S. J.; Green, A. E.; Ireton, R. C.; Zhang, Q.; Wang, H.; O'Briant, K. C.; Drescher, C. W.; Schummer, M.; McIntosh, M. W.; Knudsen, B. S.; Hanash, S. M. Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One 2008, 3 (6), e2425.
6. Rauch, A.; Bellew, M.; Eng, J.; Fitzgibbon, M.; Holzman, T.; Hussey, P.; Igra, M.; Maclean, B.; Lin, C. W.; Detter, A.; Fang, R.; Faca, V.; Gafken, P.; Zhang, H.; Whiteaker, J.; States, D.; Hanash, S.; Paulovich, A.; McIntosh, M. W. Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J. Proteome Res. 2006, 5 (1), 112-21.
7. Kall, L.; Krogh, A.; Sonnhammer, E. L. Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server. Nucleic Acids Res. 2007, 35 (Web Server issue), W429-32.
8. Liu, H.; Sadygov, R. G.; Yates, J. R., III. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76 (14), 4193-201.
9. Winter, C.; Pawel, B.; Seiser, E.; Zhao, H.; Raabe, E.; Wang, Q.; Judkins, A. R.; Attiyeh, E.; Maris, J. M. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Pediatr. Blood Cancer 2008, 51 (1), 10-6.
10. Blaheta, R. A.; Daher, F. H.; Michaelis, M.; hasenberg, C.; Wrich, E. M.; Jonas, D.; Kotchetkov, R.; Doerr, H. W.; Cinatl, J., Jr. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression. BMC Cancer 2006, 21 (6), 294.
11. Wachowiak, R.; Fiegel, H. C.; Kaifi, J. T.; Quaas, A.; Krickhahn, A.; Schurr, P. G.; Erttmann, R.; Schachner, M.; Kluth, D.; Sauter, G.; Izbicki, J. R. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors. Ann. Surg. Oncol. 2007, 14 (12), 3575-80.
12. Kuang, Y. H.; Chen, X.; Su, J.; Wu, L. S.; Liao, L. Q.; Li, D.; Chen, Z. S.; Kanekura, T. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion. Cancer Lett. 2009, 276 (2), 189-95.
13. Su, J.; Chen, X.; Kanekura, T. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett. 2009, 273 (1), 140-7.
14. Bozzo, C.; Lombardi, G.; Santoro, C.; Canonico, P. L. Involvement of beta(1) integrin in betaAP-induced apoptosis in human neuroblastoma cells. Mol. Cell. Neurosci. 2004, 25 (1), 1-8.
15. Kuroda, H.; Sugimoto, T.; Horii, Y.; Sawada, T. Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines. Med. Pediatr. Oncol. 2001, 36 (1), 118-21.
16. Kaiser, B. K.; Yim, D.; Chow, I. T.; Gonzalez, S.; Dai, Z.; Mann, H. H.; Strong, R. K.; Groh, V.; Spies, T. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 2007, 447 (7143), 482-6.
17. Shin, B. K.; Wang, H.; Yim, A. M.; Le Naour, F.; Brichory, F.; Jang, J. H.; Zhao, R.; Puravs, E.; Tra, J.; Michael, C. W.; Misek, D. E.; Hanash, S. M. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 2003, 278 (9), 7607-16.
18. Son, C. G.; Bilke, S.; Davis, S.; Greer, B. T.; Wei, J. S.; Whiteford, C. C.; Chen, Q. R.; Cenacchi, N.; Khan, J. Database of mRNA gene expression profiles of multiple human organs. Genome Res. 2005, 15 (3), 443-50.
19. Alaminos, M.; Mora, J.; Cheung, N. K.; Smith, A.; Qin, J.; Chen, L.; Gerald, W. L. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res. 2003, 63 (15), 4538-46.
20. Kiselyov, V. V.; Soroka, V.; Berezin, V.; Bock, E. Structural biology of NCAM homophilic binding and activation of FGFR. J. Neurochem. 2005, 94 (5), 1169-79.
21. Walmod, P. S.; Kolkova, K.; Berezin, V.; Bock, E. Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem. Res. 2004, 29 (11), 2015-35.
22. Arlt, M. J.; Novak-Hofer, I.; Gast, D.; Gschwend, V.; Moldenhauer, G.; Grunberg, J.; Honer, M.; Schubiger, P. A.; Altevogt, P.; Kruger, A. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res. 2006, 66 (2), 936-43.
23. Thelen, K.; Kedar, V.; Panicker, A. K.; Schmid, R. S.; Midkiff, B. R.; Maness, P. F. The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J. Neurosci. 2002, 22 (12), 4918-31.
24. MacLennan, A. J.; Gaskin, A. A.; Vinson, E. N.; Martinez, L. C. Ciliary neurotrophic factor receptor alpha mRNA in NB41A3 neuroblastoma cells: regulation by cAMP. Eur. J. Pharmacol. 1996, 295 (1), 103-8.
25. Wang, X.; Halvorsen, S. W. Retinoic acid up-regulates ciliary neurotrophic factor receptors in cultured chick neurons and cardiomyocytes. Neurosci. Lett. 1998, 240 (1), 9-12.
26. Curtin, K. D.; Meinertzhagen, I. A.; Wyman, R. J. Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture. J. Cell Sci. 2005, 118 (Pt 12), 2649-60.
27. Liang, Q.; Xiong, H.; Gao, G.; Xiong, K.; Wang, X.; Zhao, Z.; Zhang, H.; Li, Y. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis. Cancer Biol. Ther. 2005, 4 (7), 759-62.
28. Wang, L.; Wu, G.; Yu, L.; Yuan, J.; Fang, F.; Zhai, Z.; Wang, F.; Wang, H. Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference. Cancer Biol. Ther. 2006, 5 (6), 608-14.
29. Tang, Y.; Nakada, M. T.; Kesavan, P.; McCabe, F.; Millar, H.; Rafferty, P.; Bugelski, P.; Yan, L. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res. 2005, 65 (8), 3193-9.
30. Sier, C. F.; Zuidwijk, K.; Zijlmans, H. J.; Hanemaaijer, R.; Mulder-Stapel, A. A.; Prins, F. A.; Dreef, E. J.; Kenter, G. G.; Fleuren, G. J.; Gorter, A. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. Int. J. Cancer 2006, 118 (12), 2991-8.
31. Davidson, B.; Givant-Horwitz, V.; Lazarovici, P.; Risberg, B.; Nesland, J. M.; Trope, C. G.; Schaefer, E.; Reich, R. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma. Clin. Exp. Metastasis 2003, 20 (7), 621-31.
32. Chen, Z. N.; Mi, L.; Xu, J.; Song, F.; Zhang, Q.; Zhang, Z.; Xing, J. L.; Bian, H. J.; Jiang, J. L.; Wang, X. H.; Shang, P.; Qian, A. R.; Zhang, S. H.; Li, L.; Li, Y.; Feng, Q.; Yu, X. L.; Feng, Y.; Yang, X. M.; Tian, R.; Wu, Z. B.; Leng, N.; Mo, T. S.; Kuang, A. R.; Tan, T. Z.; Li, Y. C.; Liang, D. R.; Lu, W. S.; Miao, J.; Xu, G. H.; Zhang, Z. H.; Nan, K. J.; Han, J.; Liu, Q. G.; Zhang, H. X.; Zhu, P. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65 (2), 435-44.
33. Tachibana, I.; Mori, M.; Tanio, Y.; Hosoe, S.; Sakuma, T.; Osaki, T.; Ueno, K.; Kumagai, T.; Kijima, T.; Kishimoto, T. A 100-kDa protein tyrosine phosphorylation is concurrent with beta 1 integrin-mediated morphological differentiation in neuroblastoma and small cell lung cancer cells. Exp. Cell Res. 1996, 227 (2), 230-9.
34. Gladson, C. L.; Hancock, S.; Arnold, M. M.; Faye-Petersen, O. M.; Castleberry, R. P.; Kelly, D. R. Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors. Am. J. Pathol. 1996, 148 (5), 1423-34.
35. Cherubini, A.; Hofmann, G.; Pillozzi, S.; Guasti, L.; Crociani, O.; Cilia, E.; Di Stefano, P.; Degani, S.; Balzi, M.; Olivotto, M.; Wanke, E.; Becchetti, A.; Defilippi, P.; Wymore, R.; Arcangeli, A. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling. Mol. Biol. Cell 2005, 16 (6), 2972-83.
36. Heymann, D.; Harb, J.; Ringeard, S.; Blanchard, F.; Lassort, D.; Raher, S.; Godard, A. Upmodulation of alpha v beta 1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: correlation with increased cell adhesion on fibronectin. J. Cell. Biochem. 1995, 58 (3), 305-14.